These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 7686594

  • 1. Mechanism of the preserving effect of aprotinin on platelet function and its use in cardiac surgery.
    Huang H, Ding W, Su Z, Zhang W.
    J Thorac Cardiovasc Surg; 1993 Jul; 106(1):11-8. PubMed ID: 7686594
    [Abstract] [Full Text] [Related]

  • 2. Aprotinin protects platelets against the initial effect of cardiopulmonary bypass.
    van Oeveren W, Harder MP, Roozendaal KJ, Eijsman L, Wildevuur CR.
    J Thorac Cardiovasc Surg; 1990 May; 99(5):788-96; discussion 796-7. PubMed ID: 1691806
    [Abstract] [Full Text] [Related]

  • 3. Protection of single-chain urokinase-type plasminogen activator (scu-PA) in aprotinin treated cardiac surgical patients undergoing cardiopulmonary bypass.
    Spannagl M, Dooijewaard G, Dietrich W, Kluft C.
    Thromb Haemost; 1995 May; 73(5):825-8. PubMed ID: 7482410
    [Abstract] [Full Text] [Related]

  • 4. Tissue-type plasminogen activator and fibrin monomers synergistically cause platelet dysfunction during retransfusion of shed blood after cardiopulmonary bypass.
    de Haan J, Schönberger J, Haan J, van Oeveren W, Eijgelaar A.
    J Thorac Cardiovasc Surg; 1993 Dec; 106(6):1017-23. PubMed ID: 8246533
    [Abstract] [Full Text] [Related]

  • 5. Hemostasis in patients undergoing extracorporeal circulation: the effect of aprotinin (Trasylol).
    Lu H, Soria C, Commin PL, Soria J, Piwnica A, Schumann F, Regnier O, Legrand Y, Caen JP.
    Thromb Haemost; 1991 Dec 02; 66(6):633-7. PubMed ID: 1724577
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Platelets and soluble fibrin promote plasminogen activation causing downregulation of platelet glycoprotein Ib/IX complexes: protection by aprotinin.
    de Haan J, van Oeveren W.
    Thromb Res; 1998 Nov 15; 92(4):171-9. PubMed ID: 9840026
    [Abstract] [Full Text] [Related]

  • 9. Platelet function during cardiopulmonary bypass not changed by two different doses of aprotinin.
    Santamaría A, Mateo J, Muñíz-Díaz E, Oliver A, Murillo J, Litvan H, Souto JC, Fontcuberta J.
    Haematologica; 2000 Apr 15; 85(4):381-5. PubMed ID: 10756363
    [Abstract] [Full Text] [Related]

  • 10. Comparison of two aprotinin dosage regimens in pediatric patients having cardiac operations. Influence on platelet function and blood loss.
    Boldt J, Knothe C, Zickmann B, Wege N, Dapper F, Hempelmann G.
    J Thorac Cardiovasc Surg; 1993 Apr 15; 105(4):705-11. PubMed ID: 7682266
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Low doses of aprotinin in aortocoronary bypass surgery--advantages and disadvantages.
    Golański R, Golański J, Chizyński K, Iwaszkiewicz A, Zasłonka J, Pietrucha T, Chrul S, Watała C.
    Med Sci Monit; 2000 Apr 15; 6(4):722-8. PubMed ID: 11208399
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Combined administration of nitric oxide gas and iloprost during cardiopulmonary bypass reduces platelet dysfunction: a pilot clinical study.
    Chung A, Wildhirt SM, Wang S, Koshal A, Radomski MW.
    J Thorac Cardiovasc Surg; 2005 Apr 15; 129(4):782-90. PubMed ID: 15821644
    [Abstract] [Full Text] [Related]

  • 20. Role of platelet membrane glycoproteins Ib/IX and IIb/IIIa, and of platelet alpha-granule proteins in platelet aggregation induced by human osteosarcoma cells.
    Clezardin P, Drouin J, Morel-Kopp MC, Hanss M, Kehrel B, Serre CM, Kaplan C, Delmas PD.
    Cancer Res; 1993 Oct 01; 53(19):4695-700. PubMed ID: 7691402
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.